Articles by admin

As 2019 draws to a close, this is the time to reflect on some of the biggest stories of the year for cannabis… and to take a peek at what lies ahead in 2020.
So we invited our friends Justin Stekal from the National Organization for the Reform of Marijuana Laws (NORML) and Morgan Fox from the National Cannabis Industry Association (NCIA) to sit down with us for our first-ever CannaBiz Now! “Legislative Roundtable.”
For the last decade, Justin and Morgan have had their fingers on the pulse of what’s going on in Washington, D.C., particularly as it relates to marijuana policy.
In …read more […]

These days it’s easy to simply buy an index fund, and your returns should (roughly) match the market. But in our… …read more […]

The largest new position is in LKQ Corp Continue reading… …read more […]

Biadu and Deere make the list Continue reading… …read more […]

(Bloomberg) — Biogen Inc. shed more than $3 billion in market value in the past two trading sessions as a patent review of its top drug Tecfidera Wednesday raised concerns over a potential generic threat from Mylan NV.Shares fell as much as 3.7% on Thursday, the most in two months, extending losses for a third day. Analysts held different views on the trial, with Evercore ISI Umer Raffat saying the hearing went better-than-expected for Biogen, while RBC analyst Brian Abrahams said Mylan seemed to make “a slightly stronger case.”“In totality, the arguments and judges’ reactions seemed to favor MYL incrementally,” …read more […]

A bear signal flashing for Macy’s stock points to more downside ahead of Black Friday …read more […]

The resignation of top student loan official A. Wayne Johnson has caused a stir on Capitol Hill. …read more […]

Today we’ll take a closer look at Fastenal Company (NASDAQ:FAST) from a dividend investor’s perspective. Owning a… …read more […]

The world’s largest retailer’s third quarter results on Thursday showed that yet again, CEO Doug McMillon continues to pull almost all the right strings operationally. …read more […]

Disappointing earnings from Canopy Growth, Tilray and Cronos have investors hesitant to invest in the cannabis industry. Yahoo Finance’s Heidi Chung, Brian Cheung and Sibile Marcellus discuss with Entourage Effect Capital CEO Matt Hawkins on YFi AM …read more […]